Elasmogen

Description: Elasmogen develops soloMERs™, small stable biologics for treating auto-immune & inflammatory diseases using its unique platform.

Country: UK

Based in: Scotland

Founded: 2016

Funding Stage: Series A/B

Tags: ['BioTech', 'Inflammatory Diseases', 'MedTech', 'Autoimmune', 'Elasmogen', 'Scotland']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.